Aptalis, is a privately held, leading specialty pharmaceutical company providing innovative, effective therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. The Company develops and markets a broad line of prescription products to treat cystic fibrosis and a range of gastrointestinal diseases and disorders such as inflammatory bowel disease, irritable bowel syndrome, cholestatic liver diseases and complications related to pancreatic insufficiency. Aptalis’ products are marketed by its own specialized sales forces in North America and the European Union, and through commercial collaborations in many markets around the world.
IR and Communications Contact
Steve Gannon
Senior Vice President, Chief Financial Officer and Treasurer
Aptalis
597, Laurier Blvd.
Mont-Saint-Hilaire, QC, J3H 6C4
Canada
Tel: (450) 467-2600 or
1 (877) 982-2600 ext. 2442
Fax: (450) 464-9979
E-mail: Steve Gannon